# RDF export of group: Publication
<http://ctro/data#Publication_103919> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_103919> <http://www.w3.org/2000/01/rdf-schema#label> "Publication" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasTitle> "Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents : prandial premixed ( insulin lispro protamine suspension / lispro ) versus basal / bolus ( glargine / lispro ) therapy ." .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Rosenstock J" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasJournal> "Diabetes Care" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasPMID> "17934150" .
<http://ctro/data#Publication_103919> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_103931> .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Ahmann AJ" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Colon G" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Scism - Bacon J" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Jiang H" .
<http://ctro/data#Publication_103919> <http://ctro/data#hasAuthor> "Martin S" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_103931> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_103931> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial" .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasObjectiveDescription> "The purpose of this study was to compare two analog insulin therapies ( prandial premixed therapy [ PPT ] versus basal / bolus therapy [ BBT ] )" .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasCTduration> "24 - week" .
<http://ctro/data#AllocationRatio_103935> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_103936> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasConclusionComment> "Although noninferiority of PPT to BBT was not demonstrated , findings for A1C reduction , percentage of patients achieving A1C targets , hypoglycemia , and number of required injections should be considered" .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasArm> <http://ctro/data#Arm_103980> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasPopulation> <http://ctro/data#Population_103952> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_104092> .
<http://ctro/data#EvidenceQuality_103943> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasObjectiveDescription> "in type 2 diabetic patients previously treated with insulin glargine ( > or = 30 units / day ) plus oral agents , with the aim of demonstrating noninferiority of PPT to BBT ." .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#CTDesign_103950> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_103950> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasConclusionComment> "in the individual decision - making process of advancing insulin replacement to PPT versus BBT in type 2 diabetes ." .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasArm> <http://ctro/data#Arm_103989> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_104374> .
<http://ctro/data#ClinicalTrial_103931> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_104437> .
# RDF export of group: Population
<http://ctro/data#Population_103952> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_103952> <http://www.w3.org/2000/01/rdf-schema#label> "Population" .
<http://ctro/data#Population_103952> <http://ctro/data#hasPrecondition> "type 2 diabetic patients previously treated with insulin glargine ( > or = 30 units / day ) plus oral agents" .
<http://ctro/data#Ethnicity_103954> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_103952> <http://ctro/data#hasCountry> <http://ctro/data#USA> .
<http://ctro/data#Gender_103959> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_103960> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_103960> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_A1C" .
<http://ctro/data#Endpoint_103960> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#AggregationMethod_103962> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_103960> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_103964> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_103965> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_103965> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_A1C_7" .
<http://ctro/data#Endpoint_103965> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_103967> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_103965> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_103969> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_103975> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_103975> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_6.5" .
<http://ctro/data#Endpoint_103975> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_103977> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_103975> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_103979> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_104446> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_104446> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_AE_H" .
<http://ctro/data#Endpoint_104446> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_104448> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_104449> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_104450> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_103980> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_103980> <http://www.w3.org/2000/01/rdf-schema#label> "Arm_PPT" .
<http://ctro/data#Arm_103980> <http://ctro/data#hasNumberPatientsArm> "187" .
<http://ctro/data#Arm_103980> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_103998> .
<http://ctro/data#Arm_103980> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104038> .
<http://ctro/data#Arm_103980> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_104451> .
<http://ctro/data#Arm_103980> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104320> .
<http://ctro/data#Arm_103980> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104383> .
<http://ctro/data#Arm_103989> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_103989> <http://www.w3.org/2000/01/rdf-schema#label> "Arm_BBT" .
<http://ctro/data#Arm_103989> <http://ctro/data#hasNumberPatientsArm> "187" .
<http://ctro/data#Arm_103989> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_104004> .
<http://ctro/data#Arm_103989> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104065> .
<http://ctro/data#Arm_103989> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_104451> .
<http://ctro/data#Arm_103989> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_104011> .
<http://ctro/data#Arm_103989> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104347> .
<http://ctro/data#Arm_103989> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_104410> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_103998> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_103998> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_Lis50/50" .
<http://ctro/data#Intervention_103998> <http://ctro/data#hasMedication> <http://ctro/data#Medication_104017> .
<http://ctro/data#Intervention_103998> <http://ctro/data#hasFrequency> "t . i . d" .
<http://ctro/data#RelativeTime_104003> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_104004> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_104004> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_gla" .
<http://ctro/data#Intervention_104004> <http://ctro/data#hasMedication> <http://ctro/data#Medication_104031> .
<http://ctro/data#Intervention_104004> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime> .
<http://ctro/data#Intervention_104011> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_104011> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_lis" .
<http://ctro/data#Intervention_104011> <http://ctro/data#hasMedication> <http://ctro/data#Medication_104024> .
<http://ctro/data#RelativeTime_104016> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_104011> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#RelativeTime_104016> .
# RDF export of group: Medication
<http://ctro/data#Medication_104017> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_104017> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_Lis50/50" .
<http://ctro/data#Medication_104017> <http://ctro/data#hasDrug> <http://ctro/data#Lispro50/50> .
<http://ctro/data#BioAndMedicalUnit_104020> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_104021> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_104024> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_104024> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_Lis" .
<http://ctro/data#Medication_104024> <http://ctro/data#hasDrug> <http://ctro/data#Lispro> .
<http://ctro/data#BioAndMedicalUnit_104027> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_104028> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_104031> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_104031> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_gla" .
<http://ctro/data#Medication_104031> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine> .
<http://ctro/data#BioAndMedicalUnit_104034> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_104035> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_104038> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104038> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_A1C_PPT" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103960> .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasBaselineValue> "8 . 8" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasResultMeasuredValue> "6 . 95" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasPValueChangeValue> "P < 0 . 0001" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasObservedResult> "was reduced significantly from baseline for both therapies" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasTimePoint> "week 24" .
<http://ctro/data#Outcome_104038> <http://ctro/data#hasObservedResult> "Noninferiority of PPT to BBT was not demonstrated based on the prespecified noninferiority margin of 0 . 3 %" .
<http://ctro/data#Outcome_104065> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104065> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_A1C_BBT" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103960> .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasBaselineValue> "8 . 9" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasResultMeasuredValue> "6 . 78" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasPValueChangeValue> "P < 0 . 0001" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasObservedResult> "was reduced significantly from baseline for both therapies" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasTimePoint> "week 24" .
<http://ctro/data#Outcome_104065> <http://ctro/data#hasObservedResult> "Noninferiority of PPT to BBT was not demonstrated based on the prespecified noninferiority margin of 0 . 3 %" .
<http://ctro/data#Outcome_104320> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104320> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_7_PPT" .
<http://ctro/data#Outcome_104320> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103965> .
<http://ctro/data#Outcome_104320> <http://ctro/data#hasPercentageAffected> "54" .
<http://ctro/data#Outcome_104347> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104347> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_7_BBT" .
<http://ctro/data#Outcome_104347> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103965> .
<http://ctro/data#Outcome_104347> <http://ctro/data#hasPercentageAffected> "69" .
<http://ctro/data#Outcome_104383> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104383> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_6.5_PPT" .
<http://ctro/data#Outcome_104383> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103975> .
<http://ctro/data#Outcome_104383> <http://ctro/data#hasPercentageAffected> "35" .
<http://ctro/data#Outcome_104410> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104410> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_6.5_BBT" .
<http://ctro/data#Outcome_104410> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_103975> .
<http://ctro/data#Outcome_104410> <http://ctro/data#hasPercentageAffected> "50" .
<http://ctro/data#Outcome_104451> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_104451> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_AE_H" .
<http://ctro/data#Outcome_104451> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_104446> .
<http://ctro/data#Outcome_104451> <http://ctro/data#hasObservedResult> "Rates of hypoglycemia were similar for both groups" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_104092> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_104092> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_A1C" .
<http://ctro/data#DiffBetweenGroups_104092> <http://ctro/data#hasDiffGroupAbsValue> "- 0 . 22" .
<http://ctro/data#DiffBetweenGroups_104092> <http://ctro/data#hasPvalueDiff> "P = 0 . 021" .
<http://ctro/data#DiffBetweenGroups_104092> <http://ctro/data#hasConfIntervalDiff> "90 % CI - 0 . 38 to - 0 . 07" .
<http://ctro/data#DiffBetweenGroups_104092> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_104038> .
<http://ctro/data#DiffBetweenGroups_104092> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_104065> .
<http://ctro/data#DiffBetweenGroups_104374> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_104374> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_7" .
<http://ctro/data#DiffBetweenGroups_104374> <http://ctro/data#hasPvalueDiff> "P = 0 . 009" .
<http://ctro/data#DiffBetweenGroups_104374> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_104320> .
<http://ctro/data#DiffBetweenGroups_104374> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_104347> .
<http://ctro/data#DiffBetweenGroups_104437> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_104437> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_6.5" .
<http://ctro/data#DiffBetweenGroups_104437> <http://ctro/data#hasPvalueDiff> "P = 0 . 01" .
<http://ctro/data#DiffBetweenGroups_104437> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_104383> .
<http://ctro/data#DiffBetweenGroups_104437> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_104410> .
# RDF export of group: EvidenceQuality